Eric Aboagye is Professor of Cancer Pharmacology & Molecular Imaging and Director of the CRUK-EPSRC-MRC-NIHR Comprehensive Cancer Imaging Centre. He joined the college after a PhD at the CRUK Beatson Laboratories in Glasgow, UK and post-doc fellowship at The Johns Hopkins University & Hospital in Baltimore, USA. His group is interested in the discovery and development of new methods for experimental and clinical cancer molecular imaging. In the past 5 years, the team has invented and translated three novel cancer diagnostics into human application. He has acted as an advisor to GE-Healthcare, GSK, Roche and Novartis.
Professor Aboagye was recipient of the 2009 Sir Mackenzie Davidson Medal and was elected as a Fellow of the Academy of Medical Sciences in 2010. Academy Fellows are elected for outstanding contributions to the advancement of medical science, for innovative application of scientific knowledge or for conspicuous service to healthcare.
et al., 2022, An integrated clinical-MR radiomics model to estimate survival time in patients with endometrial cancer, Journal of Magnetic Resonance Imaging, ISSN:1053-1807
et al., 2022, Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy., Eur J Cancer, Vol:176, Pages:110-120
et al., 2022, Assessing the in vivo biocompatibility of molecularly imprinted polymer nanoparticles, Polymers, ISSN:2073-4360
et al., 2022, Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC, Npj Precision Oncology, Vol:6, ISSN:2397-768X, Pages:1-11
et al., 2022, A Radiomics-Based Decision Support Tool Improves Lung Cancer Diagnosis In Combination With The Herder Score in Large Lung Nodules, Ebiomedicine, ISSN:2352-3964